Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions.
This research study is looking at a new 10mg Lenvatinib capsule and comparing it to an existing medicine called Lenvima® 10mg. The main goal is to find out if both capsules deliver the medicine into the body in the same amount and at the same speed. This is really important to make sure that new versions of medicines work just as well as the original ones. We are inviting healthy volunteers to take part, and they will need to take the capsules on an empty stomach. This type of study is an early stage of medicine development, often called Phase 1, and it helps ensure the quality and effectiveness of medicines for future patients.
At a glance
What is this study about?
This study is a bit like a quality check for medicines. Imagine you have two different brands of the same common painkiller; you'd want them both to work in exactly the same way, right? This study aims to do just that for a medicine called Lenvatinib. There's an existing version, Lenvima®, and a new 10mg capsule. Scientists need to make sure that this new capsule behaves identically when it's swallowed by a person.
Specifically, they are checking something called 'bioequivalence.' This simply means they want to be sure that the new capsule releases the medicine into your bloodstream at the same rate and in the same amount as the original Lenvima® capsule. This is a crucial step before any new medicine can be made widely available. It helps to guarantee that patients will get the same benefits from the new version as they would from the established one.
Why does this matter? Well, it's all about making sure new medicines are safe and effective. If a new version of a medicine isn't absorbed properly, it might not work as intended, or it could even cause unexpected side effects. By conducting studies like this, researchers can build confidence that patients will receive consistent and reliable treatment, no matter which approved version of the medicine they are given.
Key takeaways
- Tests a new medicine against an existing one to ensure they work the same way.
- Specifically checks how much medicine gets into your blood and how fast.
- Open to healthy adults, both men and women, aged 18 and over.
- Involves taking medicine on an empty stomach and giving blood samples.
- Helps ensure new medicines are safe and reliable for future patients.
Who may be eligible?
This study is looking for healthy adults. You don't need to have any particular medical condition to take part. In fact, if you have any serious health problems, you might not be able to join.
To be considered, you must be at least 18 years old. There isn't an upper age limit mentioned, so older adults could also be eligible, as long as they are healthy enough to participate.
Both men and women are welcome to join this study. The researchers aim to have a mixed group of participants to get a good overall picture of how the medicine is absorbed.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you at least 18 years old?
- Do you consider yourself generally healthy with no major ongoing medical conditions?
- Are you comfortable with giving regular blood samples?
- Are you able to follow specific instructions, like fasting before taking medicine?
What does participation involve?
If you join this study, you'll be asked to visit the clinic a few times. During these visits, you'll take either the new Lenvatinib capsule or the existing Lenvima® capsule, typically after not eating for a certain period (fasting). Nurses and doctors will then take regular blood samples to measure how much of the medicine is in your system over time. You might also have other checks, like having your vital signs (such as blood pressure and heart rate) monitored.
After a period, you might switch and take the other capsule (if you took the new one first, you'd then take the original, and vice versa). This helps the researchers compare the two capsules in the same person. There will be follow-up checks after you've taken the medicines to ensure you're feeling well. The total duration of your participation, including all visits and follow-ups, will be explained in detail by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What does 'bioequivalence' mean?
It means the study is checking if two medicines deliver the same amount of active ingredient into your body at the same speed, making them work in the same way.
Why is this study only for healthy people?
By studying healthy individuals, researchers can see how the medicine works without the complexities of existing health conditions, making it easier to understand how the body absorbs it.
Will I get paid to participate?
Many clinical studies offer payment for your time and travel. The study team will provide details on any compensation.
What are the medicines I would take?
You would take a 10mg Lenvatinib capsule and a 10mg Lenvima® capsule, which is another brand of Lenvatinib, at different times during the study.
How long will the study last for me?
The full duration of your involvement, including all visits and follow-ups, will be explained in detail by the study coordinator.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.